跳至主要内容
临床试验/NCT07464457
NCT07464457招募中不适用

Effects of Neoadjuvant Prehabilitation on Post-Interventional Physical and Psychological Outcomes in Oncology Patients With Solid Tumors: A Prospective, Two-arm, Controlled, Monocentric Interventional Study

Priv.-Doz. Dr. med. Philipp Lenz1 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2026年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
125
试验地点
1
主要终点
Physical performance using the 6-Minute Walk Test

研究概览

简要总结

The goal of NEOPRO-SIT is to establish and evaluate a neoadjuvant prehabilitation program comprised of targeted exercise therapy and structured psycho-oncological support in patients with solid tumors.

The main question is:

Will targeted exercise therapy and structured psycho-oncological support increase both physical and psychological capacity as well of quality of life compared to standard of care in a prehabilitation setting?

Researchers will:

compare a prehabilitation program to standard of care

Participants will:

receive either standard or care or a comprehensive prehabilitation program

详细描述

The project NEOPRO-SIT aims to establish and evaluate a neoadjuvant prehabilitation program comprised of targeted exercise therapy and structured psycho-oncological support in patients with solid tumors.

NEOPRO-SIT is a prospective, two-arm, controlled, single-center interventional study evaluating the effectiveness of neoadjuvant prehabilitation in patients with solid tumors. The study compares the standard of care with a structured, closely supervised prehabilitation program. A total of 125 patients will be enrolled in this study.

The NEOPRO-SIT project evaluates whether a structured, supervised prehabilitation program during neoadjuvant therapy provides additional physical and psychological benefits compared with a low-resource consultation-based approach. Despite the limitations of a sequential non-randomized design, the study aims to establish a feasible, standardized prehabilitation concept that could improve patient outcomes and support more efficient integration of supportive care into routine oncology.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with solid tumors (focus on breastcancer)
  • Curative-intent multimodal treatment concept with local surgical or radiotherapeutic ablation
  • Working age and > 18 years
  • Sufficient language skills to understand questionnaires/training instructions

排除标准

  • Severe cardiac or pulmonary comorbidities that do not allow participation in the program
  • Medical contraindications for physical activity
  • Lack of patient capacity to consent
  • Pregnancy/breastfeeding
  • Acute infections/fever
  • Participation in another clinical intervention study

研究组 & 干预措施

Control arm

Active Comparator

Standard of care

干预措施: standard of care (Behavioral)

Prehabilitation arm

Experimental

Targeted execercise and psychooncological program

干预措施: Prehabilitation (Behavioral)

结局指标

主要结局

Physical performance using the 6-Minute Walk Test

时间窗: From enrollment to 14 - 28 days after ablative intervention

Physical performance at post-intervention (14-28 days after the ablative intervention), assessed using the 6-Minute Walk Test.

次要结局

  • Muscle strength(From enrollment to 14 - 28 days after ablative intervention)
  • Handgrip strength(From enrollment to 14 - 28 days after ablative intervention)
  • Psychological distress(From enrollment to 6 months after the ablative intervention)
  • Anxiety(From enrollment to 6 months after the ablative intervention)
  • Depression(From enrollment to 6 months after the ablative intervention)
  • Emotional regulation(From enrollment to 6 months after the ablative intervention)
  • Emotion Beliefs(From enrollment to 6 months after the ablative intervention)
  • Health-related quality of life(From enrollment to 6 months after the ablative intervention)
  • Length of hospital stay(From ablative intervention up to one month after ablative intervention)
  • Infections(From enrollment to 6 months after the ablative intervention)

研究者

发起方
Priv.-Doz. Dr. med. Philipp Lenz
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Priv.-Doz. Dr. med. Philipp Lenz

CEO of the West German Cancer Center

University Hospital Muenster

研究点 (1)

Loading locations...

相似试验